PMGC Holdings ELAB
NASDAQ ELAB
$4.70 +0.08 (+1.62%)
As of: Sep 10, 2026 · 11:58 AM EDT

PMGC Holdings (ELAB) Net Income (2022 - 2026)

PMGC Holdings' (ELAB) quarterly Net Income came in at -$4.3 million in Q2 2026, down 25245.61% year-over-year from N/an in Q2 2025, and down 15.67% quarter-over-quarter from -$3.7 million in Q1 2026.

Analysis

PMGC Holdings (ELAB) Net Income (2022 - 2026) Analysis & Trends

PMGC Holdings has disclosed Net Income across 5 years of filings, most recently posting -$4.3 million for Q2 2026.

  • In Q2 2026, Net Income fell 25245.61% year-over-year to -$4.3 million; the TTM figure through Jun 2026 stood at -$12.9 million (down 516.05% YoY), while the FY2025 annual figure was $8.4 million, up 476.26% from the prior year.
  • Net Income came in at -$4.3 million for Q2 2026 at PMGC Holdings, down from -$3.7 million in the prior quarter.
  • In the past five years, Net Income ranged from a high of $1.1 billion in Q4 2022 to a low of -$469.3 million in Q3 2022.
  • Average Net Income over 5 years is $38.9 million, with a median of -$1.4 million recorded in 2023.
  • Year-over-year, Net Income jumped 100.75% in 2025 and sank 25245.61% in 2026.
  • Over 5 years, Net Income stood at $1.1 billion in 2022, then slumped by 100.1% to -$1.1 million in 2023, then soared by 80.06% to -$216910.0 in 2024, then slumped by 1070.9% to -$2.5 million in 2025, then slumped by 69.65% to -$4.3 million in 2026.
  • Per Business Quant data, the three most recent Net Income figures were -$4.3 million in Q2 2026, -$3.7 million in Q1 2026, and -$2.5 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Amgen 207.26 Bn 193.27 Bn 7.24 Bn 2.38 Bn
2 Gilead Sciences 179.66 Bn 176.48 Bn 6.22 Bn -10.50 Bn
3 Vertex Pharmaceuticals 131.52 Bn 123.67 Bn 2.84 Bn 1.10 Bn
4 Regeneron Pharmaceuticals 81.77 Bn 73.78 Bn 3.93 Bn 1.30 Bn
5 Argenx Se 61.15 Bn 55.97 Bn 1.37 Bn 601.00 Mn
6 Moderna 53.55 Bn 48.41 Bn 52.00 Mn -782.00 Mn
7 Alnylam Pharmaceuticals 33.38 Bn 30.07 Bn 992.69 Mn 164.49 Mn
8 Biogen 31.68 Bn 30.40 Bn 1.96 Bn 97.50 Mn
9 Roivant Sciences 29.12 Bn 29.12 Bn 1.16 Mn -290.61 Mn
10 PMGC Holdings 2.29 Mn -16.50 Mn 385,691.00 -4.31 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -4.31 Mn
Mar 31, 2026 -3.72 Mn
Dec 31, 2025 -2.54 Mn
Sep 30, 2025 -2.33 Mn
Jun 30, 2025 17,135.00
Mar 31, 2025 -27,644.00
Dec 31, 2024 -216,910.00
Sep 30, 2024 -1.87 Mn
Jun 30, 2024 -2.30 Mn
Mar 31, 2024 -1.68 Mn
Dec 31, 2023 -1.09 Mn
Sep 30, 2023 -791,239.00
Jun 30, 2023 -1.06 Mn
Mar 31, 2023 -841,282.00
Dec 31, 2022 1.11 Bn
Sep 30, 2022 -469.32 Mn